FDAFDA · Food and drugs·Recall number D-0833-2020
Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.
Published February 19, 2020 · Recall initiated: December 20, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LAMOTRIGINE
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Distributor
- Nationwide in the U.S. and Puerto Rico.
- UPC
- 0351672413019
- Lot
- Lot #: 331771, Exp. June 2021
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.